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Introduction
Daily oral care with chlorhexidine has been widely
recommended as part of care bundles for ventilated
patients by organisations such as the Scottish Patient
Safety Programme (SPSP) [1], and the Institute for
Healthcare Improvement (IHI) despite studies showing
variable efficacy.
Objectives
A recent systemic review [2] and network meta-analysis
suggested that chlorhexidine used for mouth care is
associated with an increase in mortality. We therefore
developed a survey to quantify the use of chlorhexidine
in Scottish intensive care units.
Methods
On a single day, we called each of the 24 intensive care
units in Scotland and spoke to the Charge Nurse on
duty. We asked them the following questions using a
standard survey form:
1. Have you ever given chlorhexidine mouth care as
routine to all intubated patients?
2. Do you currently give chlorhexidine mouth care as
routine to all intubated patients?
3. If you stopped, when and why?
4. Are you reviewing your practice in light of recent
evidence suggesting potential harm associated?
Where appropriate, the opportunity was taken to
spread awareness of the recently published evidence.
Results
Twenty four (100%) of units have used chlorhexidine
mouth care at some stage.
Four out of 24 (17%) units no longer use chlorhexi-
dine. All of these units stopped as a direct result of the
recent meta-analysis.
Of the units still using chlorhexidine, 3 (13%) claimed
to be aware of the meta-analysis and one of these units
was currently reviewing their practise.
Conclusions
Chlorhexidine oral care has been a staple of ICU care
since the introduction of standardised bundles of care
by the SPSP. Our unit felt that the lack of clear evidence
of benefit combined with the recent evidence of excess
mortality justified discontinuing its recent use.
In an era of evidence based medicine, it is interesting to
see the rate at which best evidence is adopted, and to this
end we plan on repeating our survey after 12 months to
assess the impact of this important study.
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